Skip to content
10-Q

Quarterly Report

C4 Therapeutics, Inc. CCCC

0001628280-25-038587

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 29, 2025 71.17M sh
Shares Diluted Q2 2025 · Jun 30, 2025 71.01M sh
Shares Diluted Q2 2025 · Jun 30, 2025 70.92M sh
Shares Diluted Q2 2025 · Jun 30, 2024 68.81M sh
Shares Diluted Q2 2025 · Jun 30, 2024 68.62M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $155K
Stock Repurchased Q2 2025 · Jun 30, 2024 $109K
Capex Q2 2025 · Jun 30, 2025 $185K
Capex Q2 2025 · Jun 30, 2024 $197K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$45.34M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$23.09M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $78.16M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $55.5M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $73.11M
Stockholders Equity Q2 2025 · Jun 30, 2025 $174.06M
Stockholders Equity Q2 2025 · Mar 31, 2025 $195.14M
Stockholders Equity Q2 2025 · Dec 31, 2024 $215.99M
Stockholders Equity Q2 2025 · Jun 30, 2024 $247.06M
Stockholders Equity Q2 2025 · Mar 31, 2024 $258.28M
Stockholders Equity Q2 2025 · Dec 31, 2023 $246.11M
Current Liabilities Q2 2025 · Jun 30, 2025 $44.46M
Current Liabilities Q2 2025 · Dec 31, 2024 $45.18M
Total Liabilities Q2 2025 · Jun 30, 2025 $122.46M
Total Liabilities Q2 2025 · Dec 31, 2024 $133.62M
Current Assets Q2 2025 · Jun 30, 2025 $224.73M
Current Assets Q2 2025 · Dec 31, 2024 $257.77M
Total Assets Q2 2025 · Jun 30, 2025 $296.53M
Total Assets Q2 2025 · Dec 31, 2024 $349.6M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.37
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.74
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.26
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.67
Eps Basic Q2 2025 · Jun 30, 2025 −$0.37
Eps Basic Q2 2025 · Jun 30, 2025 −$0.74
Eps Basic Q2 2025 · Jun 30, 2024 −$0.26
Eps Basic Q2 2025 · Jun 30, 2024 −$0.67
Sga Expense Q2 2025 · Jun 30, 2025 $8.77M
Sga Expense Q2 2025 · Jun 30, 2025 $18.1M
Sga Expense Q2 2025 · Jun 30, 2024 $9.7M
Sga Expense Q2 2025 · Jun 30, 2024 $19.98M
Rd Expense Q2 2025 · Jun 30, 2025 $26.2M
Rd Expense Q2 2025 · Jun 30, 2025 $53.27M
Rd Expense Q2 2025 · Jun 30, 2024 $23.75M
Rd Expense Q2 2025 · Jun 30, 2024 $46.29M
Net Income Q2 2025 · Jun 30, 2025 −$26.02M
Net Income Q2 2025 · Jun 30, 2025 −$52.34M
Net Income Q2 2025 · Mar 31, 2025 −$26.32M
Net Income Q2 2025 · Jun 30, 2024 −$17.72M
Net Income Q2 2025 · Jun 30, 2024 −$46.08M
Net Income Q2 2025 · Mar 31, 2024 −$28.36M
Operating Income Q2 2025 · Jun 30, 2025 −$28.5M
Operating Income Q2 2025 · Jun 30, 2025 −$57.67M
Operating Income Q2 2025 · Jun 30, 2024 −$21.44M
Operating Income Q2 2025 · Jun 30, 2024 −$53.66M
Revenue Q2 2025 · Jun 30, 2025 $6.46M
Revenue Q2 2025 · Jun 30, 2025 $13.7M
Revenue Q2 2025 · Jun 30, 2024 $12.01M
Revenue Q2 2025 · Jun 30, 2024 $15.05M